由于医疗成本上升和监管问题,UnitedHealth 错过了2025年第二季度的收益预测,尽管收入增长强,但降低了全年预期. UnitedHealth missed earnings estimates in Q2 2025 due to rising medical costs and regulatory issues, lowering full-year guidance despite strong revenue growth.

联合健康集团报告了2025年第二季度每股4.08美元的收益,缺失估计,收入同比增长12.9%,达到111.62亿美元. UnitedHealth Group reported second-quarter 2025 earnings of $4.08 per share, missing estimates, with revenue up 12.9% year-over-year to $111.62 billion. 该公司将全年EPS指南修订为16.00美元,指出医疗费用较高,特别是在医疗福利方面,还有监管方面的挑战。 The company revised its full-year EPS guidance to $16.00, citing higher medical costs, especially in Medicare Advantage, and regulatory challenges. 尽管大家一致认为"适度购买"评级和358.95美元的目标价格,但由于担心医疗损失比例上升和市场前4%的下跌,该股票下跌. Despite a consensus "Moderate Buy" rating and a $358.95 target price, the stock dropped amid concerns over rising medical loss ratios and a 4% pre-market decline. 该公司保持2.6%的股息收益,通过四个部分经营,并拥有强有力的机构所有权,尽管有些公司减少了股份,而另一些公司则增加了职位。 The company maintains a 2.6% dividend yield, operates through four segments, and has strong institutional ownership, though some firms reduced stakes while others increased positions.